Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 3926 - 3950 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK08
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • nLc5Cer(d18:1/26:1(17Z))
 44261059 1567.970167 C78H141N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN08
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
  • P antigen(d18:1/26:1(17Z))
 44261291 1567.970167 C78H141N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE08
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261427 1567.970167 C78H141N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD08
  • Forssman-like iGb4(d18:1/26:1(17Z))
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261867 1567.970167 C78H141N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO08
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261931 1567.970167 C78H141N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG08
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261683 1567.970167 C78H141N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN03
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
 44260270 1565.891644 C74H135NO33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type IV H(d18:1/18:0)
 44260229 1562.891978 C74H134N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM02
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44260469 1562.891978 C74H134N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44260565 1562.891978 C74H134N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type I B antigen(d18:1/18:0)
 44260645 1562.891978 C74H134N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II B antigen(d18:1/18:0)
 44261005 1562.891978 C74H134N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV02
  • Gala 1-3Lex(d18:1/18:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261549 1562.891978 C74H134N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW02
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261613 1562.891978 C74H134N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BB02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261637 1562.891978 C74H134N2O32
Gangliosides LMSP0601BY02
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262365 1561.871577 C73H131N3O32
Gangliosides LMSP0601CJ02
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262437 1561.871577 C73H131N3O32
Gangliosides LMSP0601FF02
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
 44262981 1561.871577 C73H131N3O32
Gangliosides LMSP0601DD04
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44262583 1560.912713 C75H136N2O31
Gangliosides LMSP0601DF04
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • KDN-GM1(d18:1/22:0)
 44262599 1560.912713 C75H136N2O31
Gangliosides LMSP0601EB04
  • KDN-lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44262759 1560.912713 C75H136N2O31
Gangliosides LMSP0601EC04
  • KDN(2-6)lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44262767 1560.912713 C75H136N2O31
Gangliosides LMSP0601GE04
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44263167 1560.912713 C75H136N2O31
Gangliosides LMSP0601GG04
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/22:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
 44263183 1560.912713 C75H136N2O31
Pentaacylaminosugars LMSL01050001
  • Bordetella pertussis lipid A
 42608337 1558.989734 C78H148N2O24P2
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024